Full Archive

If it walks like a …..

Before CGM was all the rage the in thing was finding the Holy Grail of diabetes a non-invasive glucose monitor. Everyone and I do mean everyone thought that this was a can’t miss product because patients would no longer suffer through painful fingersticks. Millions perhaps billions were thrown at this technology and yep there is no FDA approved Holy Grail. It was fun covering these companies most of which were designed...

Below the water line

Since CGM technology came on the scene we have said from day one the adoption seen now is the only the tip of the iceberg. The best part is what’s not seen the much larger market opportunity the huge base of the iceberg below the water line. We have consistently noted that CGM is not just a technology for Type 1 patients or patients following intensive insulin therapy but ALL...

It doesn’t get any better than this

In baseball we’ve got Yankees Red Sox – football Bears Packers – basketball Lakers Celtics and diabetes Lilly Novo Nordisk. These two are at again and the stakes have gotten even higher as Lilly is about to invade Novo’s turf as the FDA has fast tracked tirzepatide for obesity. So just as they have done with insulin Novo and Lilly are about to butt heads again in the expanding obesity...

It will take more than 24 hours

Tonight, at sundown Jews across the globe will begin the highest of Jewish holidays the day of atonement Yom Kippur. Over 24 hours from sundown to sundown those who can begin fasting while they repent for their sins committed over the past year. Come sundown on Wednesday evening everyone has a clean slate and can begin sinning again. It’s really too bad that certain companies in our wacky world are...

Time to buy?

“An estimated 8.4 million people were living with Type 1 Diabetes (T1D) across the globe in 2021, according to the results of a new modelling study published in The Lancet Diabetes & Endocrinology. This number is predicted to increase to 13.5-17.4 million people living with T1D by 2040.” The question now becomes does this new model provide a real perspective or is it just another data set for every insulin pump...

Crazy but true

We don’t call this the wacky world of diabetes just because of the business of diabetes. This wackiness extends beyond deals done or not executed to the academic world. Largely we had given up on reporting about these stupid studies that show a connection between a woman’s breast size and diabetes or how there is a connection between red wine and diabetes. Yet we could not pass up this latest...

Poker or Solitaire?

According to a study published in the New England Journal of Medicine the iLet system from Beta Bionics. “In this 13-week, randomized trial involving adults and children with type 1 diabetes, use of a bionic pancreas was associated with a greater reduction than standard care in the glycated hemoglobin level.” What has most people excited about the system isn’t the results rather how easy the system is to use. While we would...